C.Light Technologies
Generated 5/10/2026
Executive Summary
C.Light Technologies is a privately held medical device company based in Berkeley, California, focused on developing advanced retinal imaging systems. Founded in 2015, the company aims to enable early detection and monitoring of eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy by capturing high-resolution, functional images of the retina. Its technology addresses a critical need in ophthalmology: the ability to detect disease at its earliest stages before irreversible vision loss occurs. By providing functional imaging beyond traditional structural scans, C.Light's platform could differentiate itself in the competitive retinal imaging market, which includes players like Optos (Nikon) and Heidelberg Engineering. The company operates in a growing market driven by an aging population and rising diabetes prevalence, positioning it for potential adoption in both clinical and screening settings. Despite limited public information on funding, regulatory progress, or commercial traction, C.Light appears to be in a pre-revenue development stage typical of early-stage medical device companies. Its success hinges on achieving regulatory clearance, demonstrating clinical utility, and forming strategic partnerships with healthcare providers or device distributors. The company faces challenges in a crowded market with established competitors, but its focus on functional imaging could carve a niche. Key upcoming milestones include potential FDA 510(k) submission and clinical study results, which will be critical for validating its technology and attracting investment. Given the early stage and lack of publicly disclosed data, the company's outlook is speculative but promising if it can navigate regulatory and commercial hurdles.
Upcoming Catalysts (preview)
- Q4 2026FDA 510(k) Clearance for Retinal Imaging System60% success
- Q3 2026Publication of Clinical Study Results Demonstrating Diagnostic Accuracy70% success
- Q2 2026Strategic Partnership with Major Ophthalmology Clinic Chain or Device Distributor50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)